Jeffrey Aronson MB ChB MA DPhil FRCP FB PharmacolS
Selected Publications
- Aronson Jeffrey K (2011) How to attract, retain and nurture young academic clinicians. J R Soc Med, 104(1):6-14.
- de Silva H A, Pathmeswaran Arunasalam, Ranasinha Channa D, Jayamanne Shaluka, Samarakoon Senarath B, Hittharage Ariyasena, Kalupahana Ranjith, Ratnatilaka G A, Uluwatthage Wimalasiri, Aronson Jeffrey K, Armitage Jane M, Lalloo David G, and de Silva H J (2011) Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med, 8(5):e1000435.
- Ramachandran Manoj and Aronson Jeffrey K (2011) John Bostock's first description of hayfever. J R Soc Med, 104(6):237-40.
- Ramachandran Manoj and Aronson Jeffrey K (2011) Frederick Treve's first surgical operation for appendicitis. J R Soc Med, 104(5):191-7.
- Aronson Jeffrey K and Ferner Robin E (2010) Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions. Drug Saf, 33(11):995-1002.
| jeffrey.aronson@phc.ox.ac.uk | |
| Department | Department of Primary Health Care |
Jeff Aronson
Jeff Aronson is Reader in Clinical Pharmacology at the University of Oxford, Honorary Consultant Physician to the Oxford Radcliffe Hospitals NHS Trust, and a Fellow of Green-Templeton College, Oxford.
His research interests include all aspects of clinical pharmacology, especially adverse drug reactions and interactions and monitoring therapeutic interventions.
He is President Emeritus of the British Pharmacological Society and a past Editor-in-Chief of the British Journal of Clinical Pharmacology. He is the editor and author of several books, including “The Oxford Handbook of Practical Drug Therapy” and “Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions”. He is a member of a NICE Technology Appraisal Committee, a member of the Joint Formulary Committees of the British National Formulary (BNF) and the BNF for Children, and chairman of the Nomenclature Expert Advisory Group of the British Pharmacopoeia Commission.
